JPRN-UMIN000016993已完成未知
Exploratory study for SGLT2 inhibitor -Glucose lowering action, influences of dietary habits/exercise habits on therapeutic effects, and treatment satisfaction - Canak
Kanagawa Physicians Association0 个研究点目标入组 150 人开始时间: 2015年3月31日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Received SGLT 2 inhibitors within 6 months before providing consent 2) Type 1 diabetes 3) Severe ketosis, diabetic coma or precoma within 6 months 4) Treatment with Insulin preparation and/or GLP -1 receptor agonist 5) Severe infection, been pre-/post-surgery, and serious trauma 6) Severe hepatic dysfunction 7) Moderate or severe renal dysfunction 8) Hypersensitivity to any ingredient of the study drug 9) Urinary tract infection and genital infection 10) Contraindications to undergoing oral hypoglycemic agents (DPP-4 inhibitor, Sulfonylurea, Metformin etc.) 11) Enrolled in other current clinical trials 12) Pregnancy, nursing and possibility of pregnant or plan to pregnant 13) Considered as inadequate by the principal investigator or investigator
研究者
相似试验
已完成
不适用
Investigation of SGLT2 inhibitors for normal glucose tolerancenormal glucose toleranceJPRN-UMIN000013747Dianetes and Endocrinolohgy5
招募中
不适用
Efficacy of the selective SGLT2 Inhibitor for Glycogen Storage Disease Type 1bGlycogen Storage Disease type 1bCarbohydrate Metabolism, Inborn ErrorsD005953JPRN-jRCTs071210064akanishi Koichi5
招募中
4 期
Efficacy of SGLT2 inhibitor for Non-Alcoholic Fatty Liver Diseaseon Alcoholic Fatty Liver DiseaseC06.552.241.519C18.452.394.750.149ObesityType 2 Diabetes MellitusRBR-48rxwbCentro Educacional Hyarte
已完成
Unknown
Prospective observational study of tofogliflozin in patients with type 2 diabetesType 2 DiabetesJPRN-jRCT1090220212agoya Medical Association600
已完成
不适用
The efficacy of the administration of SGLT-2 inhibitor and/or DPP-4 inhibitor in type 2 diabetic patient with basal-bolus insulin therapy.JPRN-UMIN000020742Division of Endocrinology, Department of Medicine, Chiba-Hokusoh Hospital, Nippon Medical School60
